Figure A (Caverject 01)
Caverject Injection, Powder, Lyophilized, For Solution
Product Images NDC 0009-3701
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Caverject (NDC 0009-3701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Caverject 02)
Chemical Structure (Caverject 03)
Logo (Caverject 04)
Logo (Caverject 05)
Figure A (Caverject 06)
The text provides instructions on the necessary supplies required to give a CAVERJECT injection. These supplies include a sterile powder vial of CAVERJECT, a diluent vial, a 3 mL syringe, a 29 or 30 gauge one-half inch needle, a 21-27 gauge sterile needle, and two alcohol swabs. It is important to note that the diluent vial and syringe are not supplied with CAVERJECT and must be obtained separately.*
Figure B (Caverject 07)
This text is a list of components of a syringe, including a needle cap, needle, syringe cap, tip, barrel, and plunger. The first line appears to indicate the quantity (1 syringe) and may be related to a purchase order or inventory system.*
Figure C (Caverject 08)
Figure D (Caverject 09)
Figure E (Caverject 10)
Figure F (Caverject 11)
Figure G (Caverject 12)
Figure H (Caverject 13)
Figure I (Caverject 14)
Figure J (Caverject 15)
Figure K (Caverject 16)
Figure L (Caverject 17)
Figure M (Caverject 18)
Figure N (Caverject 19)
Figure O (Caverject 20)
Figure P (Caverject 21)
This is a warning message that requests to not inject near the areas specified. The context and reasons behind the warning are not available.*
Figure Q (Caverject 22)
Figure R (Caverject 23)
Logo (Caverject 24)
Image Not Available (5 mcg)
Caverject® alprostadil for injection is a prescription medication for intracavernosal use only. It comes in a single-dose vial with an NDC number of 0009-3701-08. The solution should be stored at a temperature between 20°C to 25°C (68°F to 77°F), and once reconstituted, it should be used within 24 hours when stored below 25°C (77°F) and not refrigerated or frozen. The dosage and use information can be found in the accompanying prescribing information. To prepare the solution, add 1 mL of diluent (bacteriostatic water for injection preserved with 0.945% w/v benzyl alcohol) and swirl until the powder dissolves. The resulting concentration is 20 meg/mL, with a total of 23.2 mcg of alprostadi and 20 mg of deliverable alprostad.*
Image Not Available (10 mcg)
This is a pharmaceutical product with the brand name Caverject IR. It contains alprostadil, which is used for intracavernosal injection. The package comes with six single-dose vials. The reconstituted solution should be used within 24 hours and stored at room temperature. The specific dosage and usage instructions are provided. The product is manufactured by Phamasia & Upjohn Co. Division of PAze I, HY, Y 10017.*
Principal Display Panel (20 mcg Vial Label)
This is a description for an injectable medication called Caverject®. The medication contains alprostadil and is used for intracavernosal use only. The accompanying prescribing information must be referred to for proper dosage and use. The medication is provided in a single-dose vial and must be stored between 2°C to 8°C (36°F to 46°F) until dispensed. After dispensation, the vials can be stored at or below 25°C (77°F) for up to 3 months or until the expiration date. When reconstituted with bacteriostatic water for injection, the resulting concentration is 40 meg/mL, providing 46.4 mcg of alprostadil. It is not recommended to use a reconstituted solution once it has been stored for 24 hours, refrigerated, or frozen.*
Principal Display Panel (20 mcg Vial Package)
This is a pharmaceutical product information sheet for Caverject, a drug used for intracavernosal injection in the treatment of erectile dysfunction. The sheet provides information on dosage, storage, and reconstitution of the product and states that it needs to be used under medical supervision. The text also includes the manufacturer's name and location as well as a unique product identification number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
